ANMAT | abortion-news.info

Undaunted by Senate Loss, Argentine Abortion Advocates Forge New Tactics, Coalitions
Activists who want church-state separation are staging public withdrawals from the Catholic Church, a new web tool uses emojis to pinpoint legislators' abortion stance, and the fight to change the law may advance the case for sex education.

Aug 28, 2018
Carla McKirdy

On August 9, Argentina’s Senate rejected a bill that would have legalized abortion during the first 14 weeks of pregnancy.

Instead of feeling downtrodden, pro-choice activists are retooling and finding ingenious ways to keep the abortion issue at the forefront. From staging public renunciations of the Catholic Church, deploying social media to hold anti-abortion legislators accountable, and using the debate to advance comprehensive sexual education, they are making lemonade from the defeat.

Continued: https://rewire.news/article/2018/08/28/undaunted-by-senate-loss-argentine-abortion-advocates/

Argentina Approves Abortion Drug After Rejecting Abortion Bill

Published 16 August 2018

Argentina's National Authority of Medicine, Food and Technology (ANMAT) has authorized Laboratorio Dominguez to produce the drug under the name MISOP 200 (200µg).

Argentina has green-lighted production of an abortion drug for institutional and hospital use, despite the government's recent rejection of a bill that would have legalized abortion in the first 14 weeks of pregnancy.

The drug, known as Misoprostol, is currently available by prescription in pharmacies and hospitals mixed with diclofenac and used for gastric purposes. Imported and pricey, it's beyond the reach of much of the population, even on the black market.

Continued: https://www.telesurtv.net/english/news/Argentina-Approves-Abortion-Drug-Despite-Rejection-of-Bill-20180816-0023.html